Article ID Journal Published Year Pages File Type
5845586 Pulmonary Pharmacology & Therapeutics 2016 36 Pages PDF
Abstract
Our results suggest that activation of CB1 receptors may suppress the ROS-mediated VLCF hypersensitivity through a mechanism that is at least partly distinct from the function of TRPA1 and P2X receptors.
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
, , , ,